Article: AlphaRx Positions Itself For Future Growth With Their Proprietary Drug Delivery Technology.

Business Editors & Health/Medical Writers

RICHMOND HILL, Ontario--(BW HealthWire)--March 22, 2002

AlphaRx Inc. (OTCBB:ALRX) is re-positioning itself to capitalize on opportunities presented within the pharmaceutical industry as specialists in drug delivery technology.

"The extremely poor market conditions during the last twelve months temporarily hindered our anticipated private placement, (as announced in July, 2001) slowing down our sales and marketing expectations," explained Michael Lee, President & CEO of AlphaRx. "Through our recent stock consolidation, the introduction of our online sales strategy and continued focus on product ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!